Benefits and costs of HIV testing

D. E. Bloom, Sharon Glied

Research output: Contribution to journalArticle

Abstract

The benefits and costs of human immunodeficiency virus (HIV) testing in employment settings are examined from two points of view: that of private employers whose profitability may be affected by their testing policies and that of public policy-makers who may affect social welfare through their design of regulations related to HIV testing. The results reveal that HIV testing is clearly not cost-beneficial for most firms, although the benefits of HIV testing may outweigh the costs for some large firms that offer generous fringe-benefit packages and that recruit workers from populations in which the prevalence of HIV infection is high. The analysis also indicates that the testing decisions of unregulated employers are not likely to yield socially optimal economic outcomes and that existing state and federal legislation related to HIV testing in employment settings has been motivated primarily by concerns over social equity.

Original languageEnglish (US)
Pages (from-to)1798-1804
Number of pages7
JournalScience
Volume252
Issue number5014
StatePublished - 1991

Fingerprint

Cost-Benefit Analysis
HIV
Costs and Cost Analysis
Social Welfare
Salaries and Fringe Benefits
Virus Diseases
Public Policy
Administrative Personnel
Legislation
Economics
Population

ASJC Scopus subject areas

  • General

Cite this

Bloom, D. E., & Glied, S. (1991). Benefits and costs of HIV testing. Science, 252(5014), 1798-1804.

Benefits and costs of HIV testing. / Bloom, D. E.; Glied, Sharon.

In: Science, Vol. 252, No. 5014, 1991, p. 1798-1804.

Research output: Contribution to journalArticle

Bloom, DE & Glied, S 1991, 'Benefits and costs of HIV testing', Science, vol. 252, no. 5014, pp. 1798-1804.
Bloom DE, Glied S. Benefits and costs of HIV testing. Science. 1991;252(5014):1798-1804.
Bloom, D. E. ; Glied, Sharon. / Benefits and costs of HIV testing. In: Science. 1991 ; Vol. 252, No. 5014. pp. 1798-1804.
@article{63e2f162e85e4889808653a00f32cda6,
title = "Benefits and costs of HIV testing",
abstract = "The benefits and costs of human immunodeficiency virus (HIV) testing in employment settings are examined from two points of view: that of private employers whose profitability may be affected by their testing policies and that of public policy-makers who may affect social welfare through their design of regulations related to HIV testing. The results reveal that HIV testing is clearly not cost-beneficial for most firms, although the benefits of HIV testing may outweigh the costs for some large firms that offer generous fringe-benefit packages and that recruit workers from populations in which the prevalence of HIV infection is high. The analysis also indicates that the testing decisions of unregulated employers are not likely to yield socially optimal economic outcomes and that existing state and federal legislation related to HIV testing in employment settings has been motivated primarily by concerns over social equity.",
author = "Bloom, {D. E.} and Sharon Glied",
year = "1991",
language = "English (US)",
volume = "252",
pages = "1798--1804",
journal = "Science",
issn = "0036-8075",
publisher = "American Association for the Advancement of Science",
number = "5014",

}

TY - JOUR

T1 - Benefits and costs of HIV testing

AU - Bloom, D. E.

AU - Glied, Sharon

PY - 1991

Y1 - 1991

N2 - The benefits and costs of human immunodeficiency virus (HIV) testing in employment settings are examined from two points of view: that of private employers whose profitability may be affected by their testing policies and that of public policy-makers who may affect social welfare through their design of regulations related to HIV testing. The results reveal that HIV testing is clearly not cost-beneficial for most firms, although the benefits of HIV testing may outweigh the costs for some large firms that offer generous fringe-benefit packages and that recruit workers from populations in which the prevalence of HIV infection is high. The analysis also indicates that the testing decisions of unregulated employers are not likely to yield socially optimal economic outcomes and that existing state and federal legislation related to HIV testing in employment settings has been motivated primarily by concerns over social equity.

AB - The benefits and costs of human immunodeficiency virus (HIV) testing in employment settings are examined from two points of view: that of private employers whose profitability may be affected by their testing policies and that of public policy-makers who may affect social welfare through their design of regulations related to HIV testing. The results reveal that HIV testing is clearly not cost-beneficial for most firms, although the benefits of HIV testing may outweigh the costs for some large firms that offer generous fringe-benefit packages and that recruit workers from populations in which the prevalence of HIV infection is high. The analysis also indicates that the testing decisions of unregulated employers are not likely to yield socially optimal economic outcomes and that existing state and federal legislation related to HIV testing in employment settings has been motivated primarily by concerns over social equity.

UR - http://www.scopus.com/inward/record.url?scp=0025856509&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025856509&partnerID=8YFLogxK

M3 - Article

C2 - 1829547

AN - SCOPUS:0025856509

VL - 252

SP - 1798

EP - 1804

JO - Science

JF - Science

SN - 0036-8075

IS - 5014

ER -